Speaking of Mol Bio Podcast: Therapeutic nucleic acids—A CDMO’s view on mRNA
In the latest episode of the Speaking of Mol Bio Podcast, hosts Steve Lewis and Dr. Christian Cobaugh, CEO of Vernal Biosciences, delve into the fascinating world of mRNA technology. The COVID pandemic has brought mRNA into the spotlight, showcasing its immense potential as a therapeutic modality. Join us as Christian shares his insights on…
Absolute Gene-ius Podcast: Helping Democratize Access and Use of mRNA Technology
Podcast Abstract: In the latest episode of the Absolute Gene-ius Podcast, hosts Christina Bouwens and Dr. Christian Cobaugh, CEO of Vernal Biosciences, dive into the evolving landscape of mRNA technology. With a mission to enhance access to high-purity mRNA for researchers and drug developers, Christian shares insights from his 15 years at the forefront of…
The mRNA Monthly—August 2024 Newsletter
Rapid Single Epitope mRNA Production This article presents a synthetic DNA template (SDT) process for manufacturing single epitope mRNA, offering a flexible, cost-efficient, and rapid alternative to traditional plasmid DNA templates (PDT). Read the article to explore what can be instrumental in developing personalized cancer vaccines. EXPLORE NOW Free Online Course: mRNA as Medicines This…
The mRNA Monthly—July 2024 Newsletter
Phase 2b Autoimmune CAR-T Win Congratulations to Cartesian Therapeutics on their Phase 2b autoimmune CAR-T trial success—shifting the intensity of the cell therapy paradigm! This milestone is a testament to their innovation. It’s exciting to see mRNA as part of that approach, stirring hope for those suffering from autoimmunity. READ MORE Accelerating LNP Development for…
The mRNA Monthly—June 2024 Newsletter
mRNA Capping TechnologiesExplore this study, which compares two important mRNA capping technologies by evaluating the mRNA integrity, percent Cap1 content, dsRNA content, in vivo expression and innate immune activation in mice. Download the Poster 7 Key Benefits of a US-Based CDMOIn the fast-paced world of biopharmaceuticals, choosing the right contract development and manufacturing organization (CDMO)…
The Benefits of Partnering with a US-Based CDMO: Quality, Efficiency, and Peace of Mind
In the fast-paced world of biopharmaceuticals, choosing the right contract development and manufacturing organization (CDMO) is crucial to the success of your drug development program. At Vernal Biosciences, we pride ourselves on being a US-based CDMO that produces all products domestically. Here are key benefits of partnering with a CDMO like Vernal Biosciences: 1. Legal and Ethical StandardsCountries…